Vitamin D and calcium supplementation for three years in postmenopausal osteoporosis significantly alters bone mineral and organic matrix quality
Language English Country United States Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
27826025
DOI
10.1016/j.bone.2016.11.002
PII: S8756-3282(16)30327-1
Knihovny.cz E-resources
- Keywords
- Bone quality, Calcium, Postmenopausal osteoporosis, Raman spectroscopy, Vitamin D,
- MeSH
- Amino Acids metabolism MeSH
- Analysis of Variance MeSH
- Calcification, Physiologic drug effects MeSH
- Glycosaminoglycans metabolism MeSH
- Bone Matrix drug effects metabolism MeSH
- Humans MeSH
- Nanoparticles chemistry MeSH
- Porosity MeSH
- Osteoporosis, Postmenopausal drug therapy physiopathology MeSH
- Dietary Supplements * MeSH
- Spectrum Analysis, Raman MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Calcium pharmacology therapeutic use MeSH
- Vitamin D pharmacology therapeutic use MeSH
- Check Tag
- Humans MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Amino Acids MeSH
- Glycosaminoglycans MeSH
- pyridinoline MeSH Browser
- Calcium MeSH
- Vitamin D MeSH
Prospective, controlled clinical trials in postmenopausal osteoporosis typically compare effects of an active drug with placebo in addition to vitamin D and calcium supplementation in both treatment arms. While clinical benefits are documented, the effect of this supplementation in the placebo arm and in clinical practice on bone material composition properties is unknown. The purpose of the present study was to evaluate these bone quality indices (specifically mineral/matrix, nanoporosity, glycosaminoglycan content, mineral maturity/crystallinity, and pyridinoline content) in patients that either received long-term vitamin D (400-1200IU) and calcium (1.0-1.5g) supplementation, or did not. We have analyzed by Raman microspectroscopy the bone forming trabecular surfaces of iliac crest in pre-treatment samples of a teriparatide study and the endpoint biopsies of the control arm obtained from the HORIZON trial. In general, the mineral/matrix ratio and the glycosaminoglycan (GAG) content was higher while nanoporosity, (a surrogate for tissue water content), the mineral maturity/crystallinity (MMC) and the pyridinoline (Pyd) content was lower in patients without long-term supplementation. Moreover, all indices were significantly dependent on tissue age. In conclusion, vitamin D and calcium supplementation is associated with altered mineral and organic matrix properties.
Dept of Internal Medicine Medical University Graz Austria
Endocrinology Dept Oslo University Hospital Norway
Institute of Rheumatology Faculty of Medicine 1 Charles University Prague Czech Republic
Thyroid Endocrinology and Osteoporosis Institute Graz Austria
References provided by Crossref.org
